The role of fibroblast growth factors in tumor growth

Current Cancer Drug Targets

Volumn 9, Issue 5, 2009, Pages 639-651

  Korc, M ^a   Friesel, R E ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b Maine Medical Center Research Institute   (United States)

Author keywords

Angiogenesis neovascularization; Fibroblast growth factors; Gene expression regulation; Molecular targets; Neoplasms

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MEMBRANE PROTEIN; SEF PROTEIN; SPROUTY 1 PROTEIN; SPROUTY 2 PROTEIN; SPROUTY PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; CANCER RESISTANCE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG DESIGN; DRUG TARGETING; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; CELL SURVIVAL; FIBROBLAST GROWTH FACTORS; GENETIC DISEASES, INBORN; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69249216604     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909789057006     Document Type: Review

References (142)

1. Itoh, N.; Ornitz, D. M. Evolution of the FGF and FGFR Gene Families. Trends Genet. 2004, 20, 563-569.
2. Katoh, M.; Katoh, M. FGF Signaling Network in the Gastrointestinal Tract (Review). Int. J. Oncol. 2006, 29, 163-168.
3. Ornitz, D. M.; Itoh, N. Fibroblast Growth Factors. Genome Biol. 2001, 2, Reviews 3005.
4. Bolitho, C.; Xu, W.; Zoellner, H. Negative Feedback for Endothelial Apoptosis: A Potential Physiological Role for Fibroblast Growth Factor. J. Vasc. Res. 2008, 45, 193-204. (Pubitemid 351543143)
5. Hazan, R. B.; Phillips, G. R.; Qiao, R. F.; Norton, L.; Aaronson, S. A. Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis. J. Cell Biol. 2000, 148, 779-790.
6. Zittermann, S. I.; Issekutz, A. C. Basic Fibroblast Growth Factor (BFGF, FGF-2) Potentiates Leukocyte Recruitment to Inflammation by Enhancing Endothelial Adhesion Molecule Expression. Am. J. Pathol. 2006, 168, 835-846.
7. Takahashi, J. A.; Igarashi, K.; Oda, K.; Kikuchi, H.; Hatanaka, M. Correlation of Basic Fibroblast Growth Factor Expression Levels With the Degree of Malignancy and Vascularity in Human Gliomas. J. Neurosurg. 1992, 76, 792-798.
8. Kwabi-Addo, B.; Ozen, M.; Ittmann, M. The Role of Fibroblast Growth Factors and Their Receptors in Prostate Cancer. Endocr. Relat. Cancer 2004, 11, 709-724. (Pubitemid 40065546)
9. Lindner, V.; Majack, R. A.; Reidy, M. A. Basic Fibroblast Growth Factor Stimulates Endothelial Regrowth and Proliferation in Denuded Arteries. J. Clin. Invest. 1990, 85, 2004-2008. (Pubitemid 20192979)
10. Halaban, R. Growth Factors and Melanomas. Semin. Oncol. 1996, 23, 673-681.
11. Bian, X. W.; Du, L. L.; Shi, J. Q.; Cheng, Y. S.; Liu, F. X. Correlation of BFGF, FGFR-1 and VEGF Expression With Vascularity and Malignancy of Human Astrocytomas. Anal. Quant. Cytol. Histol. 2000, 22, 267-274.
12. Relf, M.; LeJeune, S.; Scott, P. A.; Fox, S.; Smith, K.; Leek, R.; Moghaddam, A.; Whitehouse, R.; Bicknell, R.; Harris, A. L. Expression of the Angiogenic Factors Vascular Endothelial Cell Growth Factor, Acidic and Basic Fibroblast Growth Factor, Tumor Growth Factor Beta-1, Platelet-Derived Endothelial Cell Growth Factor, Placenta Growth Factor, and Pleiotrophin in Human Primary Breast Cancer and its Relation to Angiogenesis. Cancer Res. 1997, 57, 963-969.
13. Yamanaka, Y.; Friess, H.; Buchler, M.; Beger, H. G.; Uchida, E.; Onda, M.; Kobrin, M. S.; Korc, M. Overexpression of Acidic and Basic Fibroblast Growth Factors in Human Pancreatic Cancer Correlates With Advanced Tumor Stage. Cancer Res. 1993, 53, 5289-5296. (Pubitemid 23333401)
14. Berger, W.; Setinek, U.; Mohr, T.; Kindas-Mugge, I.; Vetterlein, M.; Dekan, G.; Eckersberger, F.; Caldas, C.; Micksche, M. Evidence for a Role of FGF-2 and FGF Receptors in the Proliferation of Non-Small Cell Lung Cancer Cells. Int. J. Cancer 1999, 83, 415-423. (Pubitemid 29455767)
15. Gazzaniga, P.; Gandini, O.; Gradilone, A.; Silvestri, I.; Giuliani, L.; Magnanti, M.; Gallucci, M.; Saccani, G.; Frati, L.; Agliano, A. M. Detection of Basic Fibroblast Growth Factor mRNA in Urinary Bladder Cancer: Correlation With Local Relapses. Int. J. Oncol. 1999, 14, 1123-1127.
16. Dellacono, F. R.; Spiro, J.; Eisma, R.; Kreutzer, D. Expression of Basic Fibroblast Growth Factor and its Receptors by Head and Neck Squamous Carcinoma Tumor and Vascular Endothelial Cells. Am. J. Surg. 1997, 174, 540-544. (Pubitemid 27486022)
17. Huang, X.; Yu, C.; Jin, C.; Yang, C.; Xie, R.; Cao, D.; Wang, F.; McKeehan, W. L. Forced Expression of Hepatocyte-Specific Fibroblast Growth Factor 21 Delays Initiation of Chemically Induced Hepatocarcinogenesis. Mol. Carcinog. 2006, 45, 934-942.
18. Jin, C.; Wang, F.; Wu, X.; Yu, C.; Luo, Y.; McKeehan, W. L. Directionally Specific Paracrine Communication Mediated by Epithelial FGF9 to Stromal FGFR3 in Two-Compartment Premalignant Prostate Tumors. Cancer Res. 2004, 64, 4555-4562.
19. Clark, J. C.; Tichelaar, J. W.; Wert, S. E.; Itoh, N.; Perl, A. K.; Stahlman, M. T.; Whitsett, J. A. FGF-10 Disrupts Lung Morphogenesis and Causes Pulmonary Adenomas in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 280, L705-L715. (Pubitemid 32473172)
20. Tai, A. L.; Sham, J. S.; Xie, D.; Fang, Y.; Wu, Y. L.; Hu, L.; Deng, W.; Tsao, G. S.; Qiao, G. B.; Cheung, A. L.; Guan, X. Y. Co-Overexpression of Fibroblast Growth Factor 3 and Epidermal Growth Factor Receptor Is Correlated With the Development of Nonsmall Cell Lung Carcinoma. Cancer 2006, 106, 146-155. (Pubitemid 43032559)
21. Hu, L.; Sham, J. S.; Xie, D.; Wen, J. M.; Wang, W. S.; Wang, Y.; Guan, X. Y. Up-Regulation of Fibroblast Growth Factor 3 Is Asso ciated With Tumor Metastasis and Recurrence in Human Hepatocellular Carcinoma. Cancer Lett. 2007, 252, 36-42.
22. Kiuru-Kuhlefelt, S.; Sarlomo-Rikala, M.; Larramendy, M. L.; Soderlund, M.; Hedman, K.; Miettinen, M.; Knuutila, S. FGF4 and INT2 Oncogenes Are Amplified and Expressed in Kaposi's Sarcoma. Mod. Pathol. 2000, 13, 433-437. (Pubitemid 30225233)
23. Suzuki, K.; Tokue, A.; Kamiakito, T.; Kuriki, K.; Saito, K.; Tanaka, A. Predominant Expression of Fibroblast Growth Factor (FGF) 8, FGF4, and FGF Receptor 1 in Nonseminomatous and Highly Proliferative Components of Testicular Germ Cell Tumors. Virchows. Arch. 2001, 439, 616-621. (Pubitemid 33071198)
24. Allerstorfer, S.; Sonvilla, G.; Fischer, H.; Spiegl-Kreinecker, S.; Gauglhofer, C.; Setinek, U.; Czech, T.; Marosi, C.; Buchroithner, J.; Pichler, J.; Silye, R.; Mohr, T.; Holzmann, K.; Grasl-Kraupp, B.; Marian, B.; Grusch, M.; Fischer, J.; Micksche, M.; Berger, W. FGF5 as an Oncogenic Factor in Human Glioblastoma Multiforme: Autocrine and Paracrine Activities. Oncogene 2008, 27, 4180-4190. (Pubitemid 351969913)
25. Kornmann, M.; Ishiwata, T.; Beger, H. G.; Korc, M. Fibroblast Growth Factor-5 Stimulates Mitogenic Signaling and Is Overexpressed in Human Pancreatic Cancer: Evidence for Autocrine and Paracrine Actions. Oncogene 1997, 15, 1417-1424. (Pubitemid 27437831)
26. Heer, R.; Douglas, D.; Mathers, M. E.; Robson, C. N.; Leung, H. Y. Fibroblast Growth Factor 17 Is Over-Expressed in Human Prostate Cancer. J. Pathol. 2004, 204, 578-586. (Pubitemid 39585957)
27. Polnaszek, N.; Kwabi-Addo, B.; Wang, J.; Ittmann, M. FGF17 Is an Autocrine Prostatic Epithelial Growth Factor and Is Upregulated in Benign Prostatic Hyperplasia. Prostate 2004, 60, 18-24. (Pubitemid 38669225)
28. Sonvilla, G.; Allerstorfer, S.; Stattner, S.; Karner, J.; Klimpfinger, M.; Fischer, H.; Grasl-Kraupp, B.; Holzmann, K.; Berger, W.; Wrba, F.; Marian, B.; Grusch, M. FGF18 in Colorectal Tumour Cells: Autocrine and Paracrine Effects. Carcinogenesis 2008, 29, 15-24. (Pubitemid 351201737)
29. Desnoyers, L. R.; Pai, R.; Ferrando, R. E.; Hotzel, K.; Le, T.; Ross, J.; Carano, R.; D'Souza, A.; Qing, J.; Mohtashemi, I.; Ashkenazi, A.; French, D. M. Targeting FGF19 Inhibits Tumor Growth in Colon Cancer Xenograft and FGF19 Transgenic Hepatocellular Carcinoma Models. Oncogene 2008, 27, 85-97.
30. Powers, C. J.; McLeskey, S. W.; Wellstein, A. Fibroblast Growth Factors, Their Receptors and Signaling. Endocr. Relat. Cancer 2000, 7, 165-197.
31. Tassi, E.; Al Attar, A.; Aigner, A.; Swift, M. R.; McDonnell, K.; Karavanov, A.; Wellstein, A. Enhancement of Fibroblast Growth Factor (FGF) Activity by an FGF-Binding Protein. J. Biol. Chem. 2001, 276, 40247-40253. (Pubitemid 37391445)
32. Abuharbeid, S.; Czubayko, F.; Aigner, A. The Fibroblast Growth Factor-Binding Protein FGF-BP. Int. J. Biochem. Cell. Biol. 2006, 38, 1463-1468. (Pubitemid 43729304)
33. Dailey, L.; Ambrosetti, D.; Mansukhani, A.; Basilico, C. Mechanisms Underlying Differential Responses to FGF Signaling. Cytokine Growth Factor Rev. 2005, 16, 233-247. (Pubitemid 40616120)
34. Hart, K. C.; Robertson, S. C.; Donoghue, D. J. Identification of Tyrosine Residues in Constitutively Activated Fibroblast Growth Factor Receptor 3 Involved in Mitogenesis, Stat Activation, and Phosphatidylinositol 3-Kinase Activation. Mol. Biol. Cell 2001, 12, 931-942. (Pubitemid 33051989)
35. Hadari, Y. R.; Gotoh, N.; Kouhara, H.; Lax, I.; Schlessinger, J. Critical Role for the Docking-Protein FRS2 Alpha in FGF Receptor-Mediated Signal Transduction Pathways. Proc. Natl. Acad. Sci. USA 2001, 98, 8578-8583. (Pubitemid 32678070)
36. Udayakumar, T. S.; Stratton, M. S.; Nagle, R. B.; Bowden, G. T. Fibroblast Growth Factor-1 Induced Promatrilysin Expression Through the Activation of Extracellular-Regulated Kinases and STAT3. Neoplasia 2002, 4, 60-67.
37. Tsang, M.; Dawid, I. B. Promotion and Attenuation of FGF Signaling Through the Ras-MAPK Pathway. Sci. STKE. 2004, 2004, e17.
38. Cabrita, M. A.; Christofori, G. Sprouty Proteins, Masterminds of Receptor Tyrosine Kinase Signaling. Angiogenesis 2008, 11, 53-62.
39. Mason, J. M.; Morrison, D. J.; Basson, M. A.; Licht, J. D. Sprouty Proteins: Multifaceted Negative-Feedback Regulators of Receptor Tyrosine Kinase Signaling. Trends Cell Biol. 2006, 16, 45-54.
40. Lo, T. L.; Yusoff, P.; Fong, C. W.; Guo, K.; McCaw, B. J.; Phillips, W. A.; Yang, H.; Wong, E. S.; Leong, H. F.; Zeng, Q.; Putti, T. C.; Guy, G. R. The Ras/Mitogen-Activated Protein Kinase Pathway Inhibitor and Likely Tumor Suppressor Proteins, Sprouty 1 and Sprouty 2 Are Deregulated in Breast Cancer. Cancer Res. 2004, 64, 6127-6136.
41. Kwabi-Addo, B.; Wang, J.; Erdem, H.; Vaid, A.; Castro, P.; Ayala, G.; Ittmann, M. The Expression of Sprouty1, an Inhibitor of Fibroblast Growth Factor Signal Transduction, Is Decreased in Human Prostate Cancer. Cancer Res. 2004, 64, 4728-4735. (Pubitemid 38924514)
42. Fritzsche, S.; Kenzelmann, M.; Hoffmann, M. J.; Muller, M.; Engers, R.; Grone, H. J.; Schulz, W. A. Concomitant Down-Regulation of SPRY1 and SPRY2 in Prostate Carcinoma. Endocr. Relat. Cancer 2006, 13, 839-849.
43. McKie, A. B.; Douglas, D. A.; Olijslagers, S.; Graham, J.; Omar, M. M.; Heer, R.; Gnanapragasam, V. J.; Robson, C. N.; Leung, H. Y. Epigenetic Inactivation of the Human Sprouty2 (HSPRY2) Homologue in Prostate Cancer. Oncogene 2005, 24, 2166-2174. (Pubitemid 40516583)
44. Lee, S. A.; Ho, C.; Roy, R.; Kosinski, C.; Patil, M. A.; Tward, A. D.; Fridlyand, J.; Chen, X. Integration of Genomic Analysis and in vivo Transfection to Identify Sprouty 2 as a Candidate Tumor Suppressor in Liver Cancer. Hepatology 2008, 47, 1200-1210. (Pubitemid 351547906)
45. Sutterluty, H.; Mayer, C. E.; Setinek, U.; Attems, J.; Ovtcharov, S.; Mikula, M.; Mikulits, W.; Micksche, M.; Berger, W. Down-Regulation of Sprouty2 in Non-Small Cell Lung Cancer Contributes to Tumor Malignancy Via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms. Mol. Cancer Res. 2007, 5, 509-520. (Pubitemid 46903958)
46. Kovalenko, D.; Yang, X.; Nadeau, R. J.; Harkins, L. K.; Friesel, R. Sef Inhibits Fibroblast Growth Factor Signaling by Inhibiting FGFR1 Tyrosine Phosphorylation and Subsequent ERK Activation. J. Biol. Chem. 2003, 278, 14087-14091. (Pubitemid 36799955)
47. Zisman-Rozen, S.; Fink, D.; Ben Izhak, O.; Fuchs, Y.; Brodski, A.; Kraus, M. H.; Bejar, J.; Ron, D. Downregulation of Sef, an Inhibitor of Receptor Tyrosine Kinase Signaling, Is Common to a Variety of Human Carcinomas. Oncogene 2007, 26, 6093-6098. (Pubitemid 47373804)
48. Yang, R. B.; Ng, C. K.; Wasserman, S. M.; Komuves, L. G.; Gerritsen, M. E.; Topper, J. N. A Novel Interleukin-17 Receptor-Like Protein Identified in Human Umbilical Vein Endothelial Cells Antagonizes Basic Fibroblast Growth Factor-Induced Signaling. J. Biol. Chem. 2003, 278, 33232-33238.
49. Darby, S.; Sahadevan, K.; Khan, M. M.; Robson, C. N.; Leung, H. Y.; Gnanapragasam, V. J. Loss of Sef (Similar Expression to FGF) Expression Is Associated With High Grade and Metastatic Prostate Cancer. Oncogene 2006, 25, 4122-4127.
50. Funakami, Y.; Hata, T.; Itoh, E.; Itano, S. Effects of Some Beta-Adrenoceptor Antagonists on Orthostatic Hypotension in Repeatedly Cold- (SART-) Stressed Rats. Biol. Pharm. Bull. 2007, 30, 303-308. (Pubitemid 46255366)
51. Deng, C.; Bedford, M.; Li, C.; Xu, X.; Yang, X.; Dunmore, J.; Leder, P. Fibroblast Growth Factor Receptor-1 (FGFR-1) Is Essential for Normal Neural Tube and Limb Development. Dev. Biol. 1997, 185, 42-54.
52. Xu, X.; Weinstein, M.; Li, C.; Naski, M.; Cohen, R. I.; Ornitz, D. M.; Leder, P.; Deng, C. Fibroblast Growth Factor Receptor 2 (FGFR2)-Mediated Reciprocal Regulation Loop Between FGF8 and FGF10 Is Essential for Limb Induction. Development 1998, 125, 753-765. (Pubitemid 28108099)
53. Deng, C.; Wynshaw-Boris, A.; Zhou, F.; Kuo, A.; Leder, P. Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth. Cell 1996, 84, 911-921. (Pubitemid 26106860)
54. Weinstein, M.; Xu, X.; Ohyama, K.; Deng, C. X. FGFR-3 and FGFR-4 Function Cooperatively to Direct Alveogenesis in the Murine Lung. Development 1998, 125, 3615-3623.
55. Grose, R.; Dickson, C. Fibroblast Growth Factor Signaling in Tumorigenesis. Cytokine Growth Factor Rev. 2005, 16, 179-186. (Pubitemid 40616115)
56. Klint, P.; Kanda, S.; Kloog, Y.; Claesson-Welsh, L. Contribution of Src and Ras Pathways in FGF-2 Induced Endothelial Cell Differentiation. Oncogene 1999, 18, 3354-3364. (Pubitemid 29286981)
57. Grose, R.; Fantl, V.; Werner, S.; Chioni, A. M.; Jarosz, M.; Rudling, R.; Cross, B.; Hart, I. R.; Dickson, C. The Role of Fibroblast Growth Factor Receptor 2b in Skin Homeostasis and Cancer Development. EMBO J. 2007, 26, 1268-1278. (Pubitemid 46398706)
58. Liu, Z.; Neiss, N.; Zhou, S.; Henne-Bruns, D.; Korc, M.; Bachem, M.; Kornmann, M. Identification of a Fibroblast Growth Factor Receptor 1 Splice Variant That Inhibits Pancreatic Cancer Cell Growth. Cancer Res. 2007, 67, 2712-2719. (Pubitemid 46548959)
59. Pardo, O. E.; Wellbrock, C.; Khanzada, U. K.; Aubert, M.; Arozarena, I.; Davidson, S.; Bowen, F.; Parker, P. J.; Filonenko, V. V.; Gout, I. T.; Sebire, N.; Marais, R.; Downward, J.; Seckl, M. J. FGF-2 Protects Small Cell Lung Cancer Cells From Apoptosis Through a Complex Involving PKCepsilon, B-Raf and S6K2. EMBO J. 2006, 25, 3078-3088.
60. Vandermoere, F.; Yazidi-Belkoura, I.; Adriaenssens, E.; Lemoine, J.; Hondermarck, H. The Antiapoptotic Effect of Fibroblast Growth Factor-2 Is Mediated Through Nuclear Factor-KappaB Activation Induced Via Interaction Between Akt and IkappaB Kinase-Beta in Breast Cancer Cells. Oncogene 2005, 24, 5482-5491.
61. Faridi, A.; Rudlowski, C.; Biesterfeld, S.; Schuh, S.; Rath, W.; Schroder, W. Long-Term Follow-Up and Prognostic Significance of Angiogenic Basic Fibroblast Growth Factor (BFGF) Expression in Patients With Breast Cancer. Pathol. Res. Pract. 2002, 198, 1-5.
62. McLeskey, S. W.; Ding, I. Y.; Lippman, M. E.; Kern, F. G. MDA-MB-134 Breast Carcinoma Cells Overexpress Fibroblast Growth Factor (FGF) Receptors and Are Growth-Inhibited by FGF Ligands. Cancer Res. 1994, 54, 523-530. (Pubitemid 2022538)
63. Fenig, E.; Wieder, R.; Paglin, S.; Wang, H.; Persaud, R.; Haimovitz-Friedman, A.; Fuks, Z.; Yahalom, J. Basic Fibroblast Growth Factor Confers Growth Inhibition and Mitogen-Activated Protein Kinase Activation in Human Breast Cancer Cells. Clin. Cancer Res. 1997, 3, 135-142.
64. Maloof, P.; Wang, Q.; Wang, H.; Stein, D.; Denny, T. N.; Yahalom, J.; Fenig, E.; Wieder, R. Overexpression of Basic Fibroblast Growth Factor (FGF-2) Downregulates Bcl-2 and Promotes Apoptosis in MCF-7 Human Breast Cancer Cells. Breast Cancer Res. Treat. 1999, 56, 153-167. (Pubitemid 29494833)
65. Wang, H.; Rubin, M.; Fenig, E.; DeBlasio, A.; Mendelsohn, J.; Yahalom, J.; Wieder, R. Basic Fibroblast Growth Factor Causes Growth Arrest in MCF-7 Human Breast Cancer Cells While Inducing Both Mitogenic and Inhibitory G1 Events. Cancer Res. 1997, 57, 1750-1757. (Pubitemid 27199670)
66. Linderholm, B. K.; Lindh, B.; Beckman, L.; Erlanson, M.; Edin, K.; Travelin, B.; Bergh, J.; Grankvist, K.; Henriksson, R. Prognostic Correlation of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in 1307 Primary Breast Cancers. Clin. Breast Cancer 2003, 4, 340-347. (Pubitemid 38139589)
67. Korah, R. M.; Sysounthone, V.; Golowa, Y.; Wieder, R. Basic Fibroblast Growth Factor Confers a Less Malignant Phenotype in MDA-MB-231 Human Breast Cancer Cells. Cancer Res. 2000, 60, 733-740. (Pubitemid 30094575)
68. Korah, R.; Choi, L.; Barrios, J.; Wieder, R. Expression of FGF-2 Alters Focal Adhesion Dynamics in Migration-Restricted MDA-MB-231 Breast Cancer Cells. Breast Cancer Res. Treat. 2004, 88, 17-28. (Pubitemid 39524441)
69. Korah, R.; Das, K.; Lindy, M. E.; Hameed, M.; Wieder, R. Coordinate Loss of Fibroblast Growth Factor 2 and Laminin 5 Expression During Neoplastic Progression of Mammary Duct Epithelium. Hum. Pathol. 2007, 38, 154-160. (Pubitemid 44880211)
70. Song, S.; Wientjes, M. G.; Gan, Y.; Au, J. L. Fibroblast Growth Factors: An Epigenetic Mechanism of Broad Spectrum Resistance to Anticancer Drugs. Proc. Natl. Acad. Sci. USA 2000, 97, 8658-8663.
71. Gan, Y.; Wientjes, M. G.; Au, J. L. Expression of Basic Fibroblast Growth Factor Correlates With Resistance to Paclitaxel in Human Patient Tumors. Pharm. Res. 2006, 23, 1324-1331. (Pubitemid 43946154)
72. Fujisawa, H.; Kurrer, M.; Reis, R. M.; Yonekawa, Y.; Kleihues, P.; Ohgaki, H. Acquisition of the Glioblastoma Phenotype During Astrocytoma Progression Is Associated With Loss of Heterozygosity on 10q25-Qter. Am. J. Pathol.1999, 155, 387-394. (Pubitemid 29370389)
73. Bernard-Pierrot, I.; Ricol, D.; Cassidy, A.; Graham, A.; Elvin, P.; Caillault, A.; Lair, S.; Broet, P.; Thiery, J. P.; Radvanyi, F. Inhibition of Human Bladder Tumour Cell Growth by Fibroblast Growth Factor Receptor 2b Is Independent of its Kinase Activity. Involvement of the Carboxy-Terminal Region of the Receptor. Oncogene 2004, 23, 9201-9211. (Pubitemid 40069690)
74. Naimi, B.; Latil, A.; Fournier, G.; Mangin, P.; Cussenot, O.; Berthon, P. Down-Regulation of (IIIb) and (IIIc) Isoforms of Fibroblast Growth Factor Receptor 2 (FGFR2) Is Associated With Malignant Progression in Human Prostate. Prostate 2002, 52, 245-252. (Pubitemid 34791225)
75. Kondo, T.; Zheng, L.; Liu, W.; Kurebayashi, J.; Asa, S. L.; Ezzat, S. Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS/BRAF/Mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer Progression. Cancer Res. 2007, 67, 5461-5470. (Pubitemid 46997287)
76. Vairaktaris, E.; Ragos, V.; Yapijakis, C.; Derka, S.; Vassiliou, S.; Nkenke, E.; Yannopoulos, A.; Spyridonidou, S.; Vylliotis, A.; Papakosta, V.; Loukeri, S.; Lazaris, A.; Tesseromatis, C.; Tsigris, C.; Patsouris, E. FGFR-2 and -3 Play an Important Role in Initial Stages of Oral Oncogenesis. Anticancer Res. 2006, 26, 4217-4221.
77. Moffa, A. B.; Ethier, S. P. Differential Signal Transduction of Alternatively Spliced FGFR2 Variants Expressed in Human Mammary Epithelial Cells. J. Cell Physiol. 2007, 210, 720-731.
78. L'Hote, C. G.; Knowles, M. A. Cell Responses to FGFR3 Signalling: Growth, Differentiation and Apoptosis. Exp. Cell Res. 2005, 304, 417-431.
79. Chaffer, C. L.; Dopheide, B.; Savagner, P.; Thompson, E. W.; Williams, E. D. Aberrant Fibroblast Growth Factor Receptor Signaling in Bladder and Other Cancers. Differentiation 2007, 75, 831-842. (Pubitemid 350086171)
80. Ricol, D.; Cappellen, D.; El Marjou, A.; Gil-Diez-de-Medina, S.; Girault, J. M.; Yoshida, T.; Ferry, G.; Tucker, G.; Poupon, M. F.; Chopin, D.; Thiery, J. P.; Radvanyi, F. Tumour Suppressive Properties of Fibroblast Growth Factor Receptor 2-IIIb in Human Bladder Cancer. Oncogene 1999, 18, 7234-7243. (Pubitemid 30032102)
81. Finch, P. W.; Rubin, J. S. Keratinocyte Growth Factor Expression and Activity in Cancer: Implications for Use in Patients With Solid Tumors. J. Natl. Cancer Inst. 2006, 98, 812-824.
82. Diez de Medina, S. G.; Chopin, D.; El Marjou, A.; Delouvee, A.; LaRochelle, W. J.; Hoznek, A.; Abbou, C.; Aaronson, S. A.; Thiery, J. P.; Radvanyi, F. Decreased Expression of Keratinocyte Growth Factor Receptor in a Subset of Human Transitional Cell Bladder Carcinomas. Oncogene 1997, 14, 323-330. (Pubitemid 27073087)
83. Knowles, M. A. Novel Therapeutic Targets in Bladder Cancer: Mutation and Expression of FGF Receptors. Future Oncol. 2008, 4, 71-83.
84. Martinez-Torrecuadrada, J.; Cifuentes, G.; Lopez-Serra, P.; Saenz, P.; Martinez, A.; Casal, J. I. Targeting the Extracellular Domain of Fibroblast Growth Factor Receptor 3 With Human Single-Chain Fv Antibodies Inhibits Bladder Carcinoma Cell Line Proliferation. Clin. Cancer Res. 2005, 11, 6280-6290.
85. Matsumoto, M.; Ohtsuki, Y.; Ochii, K.; Seike, Y.; Iseda, N.; Sasaki, T.; Okada, Y.; Kurabayashi, A.; Furihata, M. Fibroblast Growth Factor Receptor 3 Protein Expression in Urothelial Carcinoma of the Urinary Bladder, Exhibiting No Association With Low-Grade and/or Non-Invasive Lesions. Oncol. Rep. 2004, 12, 967-971.
86. Ruotsalainen, T.; Joensuu, H.; Mattson, K.; Salven, P. High Pre-treatment Serum Concentration of Basic Fibroblast Growth Factor Is a Predictor of Poor Prognosis in Small Cell Lung Cancer. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1492-1495. (Pubitemid 35340391)
87. Morrison, R. S.; Yamaguchi, F.; Bruner, J. M.; Tang, M.; McKeehan, W.; Berger, M. S. Fibroblast Growth Factor Receptor Gene Expression and Immunoreactivity Are Elevated in Human Glioblastoma Multiforme. Cancer Res. 1994, 54, 2794-2799. (Pubitemid 24173776)
88. Takahashi, J. A.; Mori, H.; Fukumoto, M.; Igarashi, K.; Jaye, M.; Oda, Y.; Kikuchi, H.; Hatanaka, M. Gene Expression of Fibroblast Growth Factors in Human Gliomas and Meningiomas: Demonstration of Cellular Source of Basic Fibroblast Growth Factor mRNA and Peptide in Tumor Tissues. Proc. Natl. Acad. Sci. USA 1990, 87, 5710-5714. (Pubitemid 20240357)
89. Zagzag, D.; Miller, D. C.; Sato, Y.; Rifkin, D. B.; Burstein, D. E. Immunohistochemical Localization of Basic Fibroblast Growth Factor in Astrocytomas. Cancer Res. 1990, 50, 7393-7398.
90. McKeehan, W. L.; Wang, F.; Kan, M. The Heparan Sulfate-Fibroblast Growth Factor Family: Diversity of Structure and Function. Prog. Nucleic Acid Res. Mol. Biol. 1998, 59, 135-176.
91. Hu, Z.; Evarts, R. P.; Fujio, K.; Marsden, E. R.; Thorgeirsson, S. S. Expression of Fibroblast Growth Factor Receptors flg and bek During Hepatic Ontogenesis and Regeneration in the Rat. Cell Growth Differ. 1995, 6, 1019-1025.
92. Steiling, H.; Wustefeld, T.; Bugnon, P.; Brauchle, M.; Fassler, R.; Teupser, D.; Thiery, J.; Gordon, J. I.; Trautwein, C.; Werner, S. Fi broblast Growth Factor Receptor Signalling Is Crucial for Liver Homeostasis and Regeneration. Oncogene 2003, 22, 4380-4388. (Pubitemid 36897968)
93. Kin, M.; Sata, M.; Ueno, T.; Torimura, T.; Inuzuka, S.; Tsuji, R.; Sujaku, K.; Sakamoto, M.; Sugawara, H.; Tamaki, S.; Tanikawa, K. Basic Fibroblast Growth Factor Regulates Proliferation and Motility of Human Hepatoma Cells by an Autocrine Mechanism. J. Hepatol. 1997, 27, 677-687.
94. Huang, X.; Yu, C.; Jin, C.; Kobayashi, M.; Bowles, C.A.; Wang, F.; McKeehan, W.L. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis. Cancer Res. 2006, 66, 1481-1490.
95. Dorkin, T. J.; Robinson, M. C.; Marsh, C.; Neal, D. E.; Leung, H. Y. AFGF Immunoreactivity in Prostate Cancer and its Co-Localization With BFGF and FGF8. J. Pathol. 1999, 189, 564-569.
96. Cronauer, M. V.; Hittmair, A.; Eder, I. E.; Hobisch, A.; Culig, Z.; Ramoner, R.; Zhang, J.; Bartsch, G.; Reissigl, A.; Radmayr, C.; Thurnher, M.; Klocker, H. Basic Fibroblast Growth Factor Levels in Cancer Cells and in Sera of Patients Suffering From Proliferative Disorders of the Prostate. Prostate 1997, 31, 223-233. (Pubitemid 27247313)
97. Giri, D.; Ropiquet, F.; Ittmann, M. Alterations in Expression of Basic Fibroblast Growth Factor (FGF) 2 and its Receptor FGFR-1 in Human Prostate Cancer. Clin. Cancer Res. 1999, 5, 1063-1071. (Pubitemid 29233220)
98. Takahashi, H. [Studies on the Expression of Fibroblast Growth Factors and Fibroblast Growth Factor Receptors in Human Prostate Cancer]. Nippon. Hinyokika. Gakkai. Zasshi. 1998, 89, 836-845.
99. Hase, T.; Kawashiri, S.; Tanaka, A.; Nozaki, S.; Noguchi, N.; Kato, K.; Nakaya, H.; Nakagawa, K. Correlation of Basic Fibroblast Growth Factor Expression With the Invasion and the Prognosis of Oral Squamous Cell Carcinoma. J. Oral Pathol. Med. 2006, 35, 136-139.
100. Siddiqi, I.; Funatomi, H.; Kobrin, M. S.; Friess. H.; Büchler, M. W.; Korc, M. Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem. Biophys. Res. Commun. 1995, 215, 309-315.
101. Ishiwata, T.; Friess, H.; Buchler, M. W.; Lopez, M. E.; Korc, M. Characterization of Keratinocyte Growth Factor and Receptor Expression in Human Pancreatic Cancer. Am. J. Pathol. 1998, 153, 213-222. (Pubitemid 28317524)
102. Liu, Z.; Ishiwata, T.; Zhou, S.; Maier, S.; Henne-Bruns, D.; Korc, M.; Bachem, M.; Kornmann, M. Human Fibroblast Growth Factor Receptor 1-IIIb Is a Functional Fibroblast Growth Factor Receptor Expressed in the Pancreas and Involved in Proliferation and Movement of Pancreatic Ductal Cells. Pancreas 2007, 35, 147-157. (Pubitemid 47075569)
103. Wagner, M.; Lopez, M. E.; Cahn, M.; Korc, M. Suppression of Fibroblast Growth Factor Receptor Signaling Inhibits Pancreatic Cancer Growth in vitro and in vivo. Gastroenterology 1998, 114, 798-807. (Pubitemid 28160415)
104. Kleeff, J.; Kothari, N. H.; Friess, H.; Fan, H.; Korc, M. Adenovirus-Mediated Transfer of a Truncated Fibroblast Growth Factor (FGF) Type I Receptor Blocks FGF-2 Signaling in Multiple Pancreatic Cancer Cell Lines. Pancreas 2004, 28, 25-30. (Pubitemid 38032241)
105. Cho, K.; Ishiwata, T.; Uchida, E.; Nakazawa, N.; Korc, M.; Naito, Z.; Tajiri, T. Enhanced Expression of Keratinocyte Growth Factor and its Receptor Correlates With Venous Invasion in Pancreatic Cancer. Am. J. Pathol. 2007, 170, 1964-1974. (Pubitemid 47339270)
106. Ribatti, D.; Vacca, A.; Rusnati, M.; Presta, M. The Discovery of Basic Fibroblast Growth Factor/Fibroblast Growth Factor-2 and its Role in Haematological Malignancies. Cytokine Growth Factor Rev. 2007, 18, 327-334. (Pubitemid 46891290)
107. Firme, L.; Bush, A. B. FGF Signaling Inhibits the Proliferation of Human Myeloma Cells and Reduces c-myc Expression. BMC. Cell Biol. 2003, 4, 17.
108. Ishikawa, H.; Tsuyama, N.; Liu, S.; Abroun, S.; Li, F. J.; Otsuyama, K.; Zheng, X.; Ma, Z.; Maki, Y.; Iqbal, M. S.; Obata, M.; Kawano, M. M. Accelerated Proliferation of Myeloma Cells by Interleukin-6 Cooperating With Fibroblast Growth Factor Receptor 3-Mediated Signals. Oncogene 2005, 24, 6328-6332.
109. Bisping, G.; Leo, R.; Wenning, D.; Dankbar, B.; Padro, T.; Kropff, M.; Scheffold, C.; Kroger, M.; Mesters, R. M.; Berdel, W. E.; Kienast, J. Paracrine Interactions of Basic Fibroblast Growth Factor and Interleukin-6 in Multiple Myeloma. Blood 2003, 101, 2775-2783. (Pubitemid 36857643)
110. Masih-Khan, E.; Trudel, S.; Heise, C.; Li, Z.; Paterson, J.; Nadeem, V.; Wei, E.; Roodman, D.; Claudio, J. O.; Bergsagel, P. L.; Stewart, A. K. MIP-1alpha (CCL3) Is a Downstream Target of FGFR3 and RAS-MAPK Signaling in Multiple Myeloma. Blood 2006, 108, 3465-3471.
111. Chesi, M.; Brents, L. A.; Ely, S. A.; Bais, C.; Robbiani, D. F.; Mesri, E. A.; Kuehl, W. M.; Bergsagel, P. L. Activated Fibroblast Growth Factor Receptor 3 Is an Oncogene That Contributes to Tumor Progression in Multiple Myeloma. Blood 2001, 97, 729-736.
112. Lauring, J.; Abukhdeir, A. M.; Konishi, H.; Garay, J. P.; Gustin, J. P.; Wang, Q.; Arceci, R. J.; Matsui, W.; Park, B. H. The Multiple Myeloma Associated MMSET Gene Contributes to Cellular Adhesion, Clonogenic Growth, and Tumorigenicity. Blood 2008, 111, 856-864.
113. Wu, X.; Jin, C.; Wang, F.; Yu, C.; McKeehan, W. L. Stromal Cell Heterogeneity in Fibroblast Growth Factor-Mediated Stromal-Epithelial Cell Cross-Talk in Premalignant Prostate Tumors. Cancer Res. 2003, 63, 4936-4944.
114. Tsunoda, S.; Nakamura, T.; Sakurai, H.; Saiki, I. Fibroblast Growth Factor-2-Induced Host Stroma Reaction During Initial Tumor Growth Promotes Progression of Mouse Melanoma Via Vascular Endothelial Growth Factor A-Dependent Neovascularization. Cancer Sci. 2007, 98, 541-548. (Pubitemid 46562745)
115. Yang, F.; Strand, D. W.; Rowley, D. R. Fibroblast Growth Factor-2 Mediates Transforming Growth Factor-Beta Action in Prostate Cancer Reactive Stroma. Oncogene 2008, 27, 450-459.
116. Alves, C. C.; Carneiro, F.; Hoefler, H.; Becker, K. F. Role of the Epithelial-Mesenchymal Transition Regulator Slug in Primary Human Cancers. Front. Biosci. 2009, 14, 3035-3050.
117. Savagner, P.; Yamada, K. M.; Thiery, J. P. The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor-Induced Epithelial-Mesenchymal Transition. J. Cell. Biol. 1997, 137, 1403-1419.
118. Pon, Y. L.; Zhou, H. Y.; Cheung, A. N.; Ngan, H. Y.; Wong, A. S. p70 S6 Kinase Promotes Epithelial to Mesenchymal Transition Through Snail Induction in Ovarian Cancer Cells. Cancer Res. 2008, 68, 6524-6532.
119. Suyama, K.; Shapiro, I.; Guttman, M.; Hazan, R. B. A Signaling Pathway Leading to Metastasis Is Controlled by N-Cadherin and the FGF Receptor. Cancer Cell 2002, 2, 301-314.
120. Abraham, J. A.; Mergia, A.; Whang, J. L.; Tumolo, A.; Friedman, J.; Hjerrild, K. A.; Gospodarowicz, D.; Fiddes, J. C. Nucleotide Sequence of a Bovine Clone Encoding the Angiogenic Protein, Basic Fibroblast Growth Factor. Science 1986, 233, 545-548. (Pubitemid 16019907)
121. Maciag, T.; Mehlman, T.; Friesel, R.; Schreiber, A. B. Heparin Binds Endothelial Cell Growth Factor, the Principal Endothelial Cell Mitogen in Bovine Brain. Science 1984, 225, 932-935.
122. Javerzat, S.; Auguste, P.; Bikfalvi, A. The Role of Fibroblast Growth Factors in Vascular Development. Trends Mol. Med. 2002, 8, 483-489.
123. Bastaki, M.; Nelli, E. E.; Dell'Era, P.; Rusnati, M.; Molinari-Tosatti, M. P.; Parolini, S.; Auerbach, R.; Ruco, L. P.; Possati, L.; Presta, M. Basic Fibroblast Growth Factor-Induced Angiogenic Phenotype in Mouse Endothelium: A Study of Aortic and Microvascular Endothelial Cell Lines. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 454-464. (Pubitemid 27133134)
124. Dell'Era, P.; Belleri, M.; Stabile, H.; Massrdi, M. L.; Ribatti, D.; Presta, M. Paracrine and Autocrine Effects of Fibroblast Growth Factor-4 in Endothelial Cells. Oncogene 2001, 20, 2655-2663. (Pubitemid 32525296)
125. Casanovas, O.; Hicklin, D. J.; Bergers, G.; Hanahan, D. Drug Resistance by Evasion of Antiangiogenic Targeting of VEGF Signaling in Late-Stage Pancreatic Islet Tumors. Cancer Cell. 2005, 8, 299-309. (Pubitemid 41443415)
126. Jubb, A. M.; Oates, A. J.; Holden, S.; Koeppen, H. Predicting Benefit From Anti-Angiogenic Agents in Malignancy. Nat. Rev. Cancer 2006, 6, 626-635. (Pubitemid 44140860)
127. Presta, M.; Dell'Era, P.; Mitola, S.; Moroni, E.; Ronca, R.; Rusnati, M. Fibroblast Growth Factor/Fibroblast Growth Factor Receptor System in Angiogenesis. Cytokine Growth Factor Rev. 2005, 16, 159-178. (Pubitemid 40616114)
128. Giavazzi, R.; Sennino, B.; Coltrini, D.; Garofalo, A.; Dossi, R.; Ronca, R.; Tosatti, M. P. M.; Presta, M. Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tu mor Growth and Angiogenesis. Am. J. Pathol. 2003, 162, 1913-1926. (Pubitemid 36613049)
129. Tille, J. C.; Wood, J.; Mandriota, S. J.; Schnell, C.; Ferrari, S.; Mestan, J.; Zhu, Z.; Witte, L.; Pepper, M. S. Vascular Endothelial Growth Factor (VEGF) Receptor-2 Antagonists Inhibit VEGF- and Basic Fibroblast Growth Factor-Induced Angiogenesis in vivo and in vitro. J. Pharmacol. Exp. Ther. 2001, 299, 1073-1085.
130. Auguste, P.; Gursel, D. B.; Lemiere, S.; Reimers, D.; Cuevas, P.; Carceller, F.; Di Santo, J. P.; Bikfalvi, A. Inhibition of Fibroblast Growth Factor/Fibroblast Growth Factor Receptor Activity in Glioma Cells Impedes Tumor Growth by Both Angiogenesis-Dependent and -Independent Mechanisms. Cancer Res. 2001, 61, 1717-1726. (Pubitemid 34292610)
131. Seghezzi, G.; Patel, S.; Ren, C. J.; Gualandris, A.; Pintucci, G.; Robbins, E. S.; Shapiro, R. L.; Galloway, A. C.; Rifkin, D. B.; Mignatti, P. Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis. J. Cell Biol. 1998, 141, 1659-1673.
132. Kanda, S.; Miyata, Y.; Kanetake, H. Fibroblast Growth Factor-2- Mediated Capillary Morphogenesis of Endothelial Cells Requires Signals Via Flt-1/Vascular Endothelial Growth Factor Receptor-1: Possible Involvement of c-Akt. J. Biol. Chem. 2004, 279, 4007-4016. (Pubitemid 38198983)
133. Gabler, C.; Plath-Gabler, A.; Killian, G. J.; Berisha, B.; Schams, D. Expression Pattern of Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) System Members in Bovine Corpus Luteum Endothelial Cells During Treatment With FGF-2, VEGF or Oestradiol. Reprod. Domest. Anim. 2004, 39, 321-327. (Pubitemid 39348367)
134. Liu, W.; Parikh, A. A.; Stoeltzing, O.; Fan, F.; McCarty, M. F.; Wey, J.; Hicklin, D. J.; Ellis, L. M. Upregulation of Neuropilin-1 by Basic Fibroblast Growth Factor Enhances Vascular Smooth Muscle Cell Migration in Response to VEGF. Cytokine 2005, 32, 206-212.
135. Shi, Y. H.; Bingle, L.; Gong, L. H.; Wang, Y. X.; Corke, K. P.; Fang, W. G. Basic FGF Augments Hypoxia Induced HIF1-Alpha Expression and VEGF Release in T47D Breast Cancer Cells. Pathology 2007, 39, 396-400.
136. Matsuo, M.; Yamada, S.; Koizumi, K.; Sakurai, H.; Saiki, I. Tumour-Derived Fibroblast Growth Factor-2 Exerts Lymphangiogenic Effects Through Akt/mTOR/p70S6kinase Pathway in Rat Lymphatic Endothelial Cells. Eur. J. Cancer 2007, 43, 1748-1754. (Pubitemid 47042372)
137. Nissen, L. J.; Cao, R.; Hedlund, E. M.; Wang, Z.; Zhao, X.; Wetterskog, D.; Funa, K.; Brakenhielm, E.; Cao, Y. Angiogenic Factors FGF2 and PDGF-BB Synergistically Promote Murine Tumor Neovascularization and Metastasis. J. Clin. Invest. 2007, 117, 2766-2777.
138. Webster, M. K.; Donoghue, D. J. FGFR Activation in Skeletal Disorders: Too Much of a Good Thing. Trends Genet. 1997, 13, 178-182. (Pubitemid 27219582)
139. Passos-Bueno, M. R.; Wilcox, W. R.; Jabs, E. W.; Sertie, A. L.; Alonso, L. G.; Kitoh, H. Clinical Spectrum of Fibroblast Growth Factor Receptor Mutations. Hum. Mutat. 1999, 14, 115-125. (Pubitemid 29372778)
140. Dode, C.; Levilliers, J.; Dupont, J. M.; De Paepe, A.; Le Du, N.; Soussi-Yanicostas, N.; Coimbra, R. S.; Delmaghani, S.; Compain-Nouaille, S.; Baverel, F.; Pecheux, C.; Le Tessier, D.; Cruaud, C.; Delpech, M.; Speleman, F.; Vermeulen, S.; Amalfitano, A.; Bachelot, Y.; Bouchard, P.; Cabrol, S.; Carel, J. C.; Delemarre-van de Waal, H.; Goulet-Salmon, B.; Kottler, M. L.; Richard, O.; Sanchez-Franco, F.; Saura, R.; Young, J.; Petit, C.; Hardelin, J. P. Loss-of-Function Mutations in FGFR1 Cause Autosomal Dominant Kallmann Syndrome. Nat. Genet. 2003, 33, 463-465. (Pubitemid 36390006)
141. Pitteloud, N.; Acierno, J. S., Jr.; Meysing, A.; Eliseenkova, A. V.; Ma, J.; Ibrahimi, O. A.; Metzger, D. L.; Hayes, F. J.; Dwyer, A. A.; Hughes, V. A.; Yialamas, M.; Hall, J. E.; Grant, E.; Mohammadi, M.; Crowley, W. F. Jr. Mutations in Fibroblast Growth Factor Receptor 1 Cause Both Kallmann Syndrome and Normosmic Idiopathic Hypogonadotropic Hypogonadism. Proc. Natl. Acad. Sci. USA 2006, 103, 6281-6286.
142. Falardeau, J.; Chung, W. C.; Beenken, A.; Raivio, T.; Plummer, L.; Sidis, Y.; Jacobson-Dickman, E. E.; Eliseenkova, A. V.; Ma, J.; Dwyer, A.; Quinton, R.; Na, S.; Hall, J. E.; Huot, C.; Alois, N.; Pearce, S. H.; Cole, L. W.; Hughes, V.; Mohammadi, M.; Tsai, P.; Pitteloud, N. Decreased FGF8 Signaling Causes Deficiency of Gonadotropin-Releasing Hormone in Humans and Mice. J. Clin. Invest. 2008, 118, 2822-2831.